Last reviewed · How we verify
NCT05681169
Schoolbased HPV-counselling and -Vaccination
NA trial testing School-based HPV-counselling and HPV-vaccination. in HPV in 640 participants. Completed in 1 May 2024.
1 September 2023
Quick facts
| Lead sponsor | University of Aarhus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 640 |
| Start date | 1 August 2022 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- School-based HPV-counselling and HPV-vaccination.
Conditions studied
- HPV — all drugs for HPV →
- Complex Intervention — all drugs for Complex Intervention →
Sponsor
University of Aarhus
Who can join
Adults 9 to 15, any sex, with HPV or Complex Intervention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed as a non-randomized implementation study consisting of a user-centered school-based HPV-counselling and HPV-vaccination (HPVV) program. The aim is to improve HPVV coverage among children with ethnic minority background with minimum 10%-point in the intervention group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
"Two shots for life. HPV-vaccination at your school". Co-creation of a complex intervention to reduce ethnic inequity in childhood HPV-vaccination in Denmark.
Leonhard AK, Badre-Esfahani SK, Larsen MB, Petersen LK, et al · · 2025 · PMID 40833975 · DOI 10.1371/journal.pone.0323870
Verify or expand the search:
- PubMed search for NCT05681169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HPV
Currently open trials in the same condition.
- NCT07493928 — HPV After chemoRadioTherapy · recruiting
- NCT07065630 — Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer · Phase 2 · recruiting
- NCT06796738 — Advancing Cervical Cancer Screening Through the Emergency Department - IIS · NA · active not recruiting
- NCT07273383 — Self-sampling for HPV Screening · NA · active not recruiting
- NCT07438080 — Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Ri · NA · recruiting
Other University of Aarhus trials
Trials by the same sponsor.
- NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
- NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
- NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05681169 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
- Last refreshed: 20 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05681169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing